This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Healthy
and you are
between 18 and 55
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single oral dose of CC-220 and to explore the effect of food on the bioavailability of CC-220 in healthy subjects

Provided treatments

  • Drug: CC-220 0.03 mg
  • Drug: CC-220 0.1 mg
  • Drug: CC-220 0.3 mg
  • Drug: CC-220 1 mg
  • Drug: CC-220 2 mg
  • Drug: Placebo
  • Drug: CC-220
  • Drug: CC-220
  • Drug: CC-220
Tris trial is registered with FDA with number: NCT01733875. The sponsor of the trial is Celgene Corporation and it is looking for 65 volunteers for the current phase.
Official trial title:
A Phase 1, Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of CC-220 and to Explore the Effect of Food on the Bioavailability of CC-220 in Healthy Subjects